Eli Lilly and Company’s Olumiant (baricitinib) has been recommended for approval in Europe for adolescents with severe ...
Discover how high-throughput antibody screening accelerates therapeutic and vaccine development, enabling faster biologics ...
Atrium Therapeutics Inc. has launched as a newly independent, publicly traded company dedicated to delivering RNA therapeutics.
WuXi XDC Cayman Inc. has entered a strategic collaboration with Earendil Labs on WuXi XDC's proprietary WuXiTecan-2 payload-linker technology platform.
SK bioscience, IDT Biologika, and Vaxxas will collaborate on a next-generation influenza vaccine development initiative.
Asahi Kasei Pharma has entered an exclusive global license agreement with Alchemedicine covering novel lead compounds for a ...
Nexus Precision Health, a precision medicine technology company, has acquired Leal Health, an AI-powered patient ...
Alkermes, a global biopharmaceutical company headquartered in Ireland, is transitioning to a new Chief Executive Officer (CEO ...
Boehringer Ingelheim has acquired an exclusive license for a preclinical, small molecule program from Sitryx Therapeutics.
Learn why Water for Injection (WFI) is a strategic utility in sterile drug manufacturing and how outsourcing WFI production ...
The FDA has granted full approval to Pfizer Inc.’s Braftovi when used with Eli Lilly’s Erbitux (cetuximab) and fluorouracil‑based chemotherapy for adults with metastatic colorectal cancer carrying a ...
Astellas Pharma Inc. and Vir Biotechnology Inc. have entered into a global strategic collaboration to advance VIR-5500.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results